Thyrocare Technologies Other Announcement

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.

Value

₹141.4 Cr

Thyrocare Technologies Annual General Meeting

Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.

Thyrocare Technologies Earnings Call Transcript: Key Takeaways

Thyrocare reports robust 24% growth, pivoting from volume-led routine testing to specialized diagnostics under new management. High operational leverage is evident as PAT growth significantly outpaced revenue.

Call

Guides 20% growth

Thyrocare Technologies Investor Presentation: Key Takeaways

Q2 FY27 consolidated revenue ₹270.8 Cr (+25.1%), EBITDA ₹89.3 Cr (33.0% margin), PAT before exceptions ₹60.2 Cr (+25.7%). Debt-free; NHL radiology divestment pending.

Thyrocare Technologies Results Update

Thyrocare Technologies reported Q2FY27 consolidated revenue of Rs 270.8 Cr, up 25.1% YoY, with PAT before exceptions of Rs 60.2 Cr. The press release also notes a Rs 45 Cr non-cash NHL impairment tied to a proposed divestment.

Thyrocare Technologies Q2 FY27 Results: Net Profit ₹15.2 Cr, Down 68.2% YoY

Thyrocare Technologies Ltd reported revenue from operations of ₹270.8 Cr (+25.1% YoY) and net profit of ₹15.2 Cr (-68.2% YoY) for Q2 FY27.

Key figure

Net profit ₹15.2 Cr · -68.2% YoY

Command Polymers Other Announcement

Command Polymers is exempt from related party transaction reporting under Regulation 23(9) for the half year ended 30 September 2026. It is SME-listed.

Carver Roboweld Other Announcement

Carver Roboweld Ltd filed its quarterly shareholding pattern as of 02 Nov 2026. Promoter and promoter group hold about 65.77% of the paid-up capital.

Krishival Foods Other Announcement

Krishival Foods filed its quarterly statement on utilisation of rights issue proceeds. No deviation from stated objects was reported for the quarter ended September 30, 2026.

Ajwa Fun World & Resorts Other Announcement

Ajwa Fun World appointed M/s. YAN & CO. as Secretarial Auditor from 4 November 2026 to fill the casual vacancy left by V. N. Vasani & Associates. The appointment runs until the next AGM.

Execution

4 November 2026 until the conclusion of the ensuing AGM (Secretarial Audit for FY 2026-27)

GMM Pfaudler Other Announcement

GMM Pfaudler revised its list of KMPs authorised to determine material events under Regulation 30(5). The filing names the Managing Director, Group CEO, Group CFO and Company Secretary as the contacts.

iSERA Lifesciences Other Announcement

iSERA Lifesciences will not comply with Regulation 23(9) for the half year ended 30 September 2026. Its capital and net worth are below exemption thresholds.